TenderlineUK
Procurement Intelligence
Search
Find a TenderClosedTender notice
Published 12 Mar 2026, 15:55 GMT

Official UK procurement notice

NHS National Framework for Ferric Carboxymaltose injection

Official notice

Authority: NHS England (Central government)

Framework agreementGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)East Midlands (UKF)
+4 moreWest Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Framework ceiling (notional)£38,217,000framework ceiling, not attributable revenue · 2 value updates
Submissions closed 29 Sept 2026
Next notice expected 26 Aug 2026
Framework period 1 yr 11 moends 31 Jan 2029 · up to 31 Jan 2031 with extensions · starts 1 Mar 2027

What is being bought

Published requirement description

Project title: NHS National Framework for Ferric Carboxymaltose Injection

Offer reference number: CM/TNS/26/5743

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

CM/TNS/26/5743 Ferric Carboxymaltose Injection

Lot 1 CESW 01/03/2027 to 31/01/2029 (23 months)

Lot 2 NWLN 01/03/2027 to 31/05/2028 (15 months)

Lot 3 LSNE 01/03/2027 to 31/05/2028 (15 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Open framework
Call-offs
every call-off is a further competition among the appointed suppliers
Framework period
1 yr 11 mo · up to 3 yrs 11 mo from 1 Mar 2027
Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

The lotProcurement structure

single lot · value published
Lot #1Renewal 1 yr 11 moSMEPublished value£38,217,000
Contract period: 1 Mar 2027 – 31 Jan 2029 (1 yr 11 mo) · up to 31 Jan 2031 with extensionsValue: £38,217,000 exc. VAT · £45,860,400 inc. VAT
Delivery: North East, North West, East Midlands, West Midlands, East of England, South East, South WestEligibility: SME eligible
Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Price: 100%
Published sub-criteria (1)
  • Price is not the only award criterion: 100%
Published award criteria (1)
  • Price is not the only award criterion
What this means for your bid
  • Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NHS National Framework for Ferric Carboxymaltose injection” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Closed
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
12 Mar 2026, 15:55 GMT
Last source update
28 Aug 2026, 10:21 BST
Award evaluation window
Submission end – 28 Oct 2026
Authority reference
CM/TNS/26/5743
FTS notice number
2026/S 000-082061
Latest notice
Tender notice (UK4)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-0668bd Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
29 Sept 2026, 13:00 BST
Clarification deadline
22 Sept 2026, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address

Tenders must be submitted to the abovementioned address

Timeline

12 Mar 2026 → 1 Mar 2027 · 8 dates
  1. Planning notice published227 days ago
    12 Mar 2026, 15:55 GMT
  2. Market engagement80 days ago
    5 Aug 2026, 23:59 BST

    NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.

    The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.

    Please contact [email protected] or [email protected] to register your interest in tendering for this framework.

  3. Next notice expected59 days ago
    26 Aug 2026, 23:59 BST
  4. Tender notice published58 days ago
    28 Aug 2026, 10:21 BST
  5. Clarification questions by33 days ago
    22 Sept 2026, 13:00 BST
  6. Admission / appointment period ends26 days ago · period end, not a bid countdown
    29 Sept 2026, 13:00 BST
  7. Today
    25 Oct 2026
  8. Award decision expected byin 4 days
    28 Oct 2026, 23:59 GMT
  9. Contract startsin 127 days
    1 Mar 2027

Notice history

8 events · 4 releases on Find a Tender · since 12 Mar 2026
  1. Pipeline notice published
    12 Mar 2026, 15:55 GMT
    UK1
  2. Pipeline notice published
    14 Jul 2026, 17:05 BST
    UK1
  3. Preliminary market engagement notice published
    21 Jul 2026, 12:50 BST
    UK2
  4. Published value updated to £62,633,000
    21 Jul 2026, 12:50 BST
    was £105,000,000
  5. Tender notice published
    28 Aug 2026, 10:21 BST
    UK4
  6. Published value updated to £38,217,000
    28 Aug 2026, 10:21 BST
    was £62,633,000
  7. Status changed to active
    28 Aug 2026, 10:21 BST
  8. Deadline published: 29 Sept 2026, 13:00 BST
    28 Aug 2026, 10:21 BST
Published amendments (1)

Estimated Publication Date changed from 01/07/2026 to 26/08/2026 Estimated Contract Start Date changed from 01/01/2027 to 01/03/2027

Routine re-releases (4)
  • 2026-03: 1 release · 12 Mar 2026

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact email

Official documents & specifications (16)

Official links; attachments are not copied

Tender pack and attachments

Show 4 more documents

Notices published for this procedure

  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender
  • Preliminary market engagement notice planningPreliminary market engagement noticeUK2Preliminary market engagement notice on Find a Tender
  • Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender
  • Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender